• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease.

出版信息

Kidney Int. 2020 Oct;98(4S):S1-S115. doi: 10.1016/j.kint.2020.06.019.

DOI:10.1016/j.kint.2020.06.019
PMID:32998798
Abstract
摘要

相似文献

1
KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease.KDIGO 2020慢性肾脏病糖尿病管理临床实践指南
Kidney Int. 2020 Oct;98(4S):S1-S115. doi: 10.1016/j.kint.2020.06.019.
2
KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease.KDIGO 2022慢性肾脏病糖尿病管理临床实践指南
Kidney Int. 2022 Nov;102(5S):S1-S127. doi: 10.1016/j.kint.2022.06.008.
3
Diabetes, cardiovascular disease, and chronic kidney disease in South Asia: current status and future directions.南亚的糖尿病、心血管疾病和慢性肾脏病：现状与未来方向
BMJ. 2017 Apr 11;357:j1420. doi: 10.1136/bmj.j1420.
4
Diagnosis and treatment of diabetic kidney disease.糖尿病肾病的诊断与治疗。
Am J Med Sci. 2014 May;347(5):406-13. doi: 10.1097/MAJ.0000000000000185.
5
Diabetes/Kidney/Heart Disease.糖尿病/肾脏/心脏病。
Cardiol Clin. 2019 Aug;37(3):ix-x. doi: 10.1016/j.ccl.2019.04.011. Epub 2019 May 15.
6
The KDIGO guidelines on diabetes and chronic kidney disease, 2020: An appraisal.《2020年改善全球肾脏病预后组织（KDIGO）糖尿病和慢性肾脏病指南：一项评估》
Diabet Med. 2021 Jul;38(7):e14561. doi: 10.1111/dme.14561. Epub 2021 Mar 31.
7
Comments on 'KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease'.对《KDIGO 2012慢性肾脏病评估与管理临床实践指南》的评论
Kidney Int. 2013 Sep;84(3):622-3. doi: 10.1038/ki.2013.243.
8
KDOQI US commentary on the 2013 KDIGO Clinical Practice Guideline for Lipid Management in CKD.KDIGO 美国专家组关于 2013 年改善全球肾脏病预后组织（KDIGO）慢性肾脏病血脂管理临床实践指南的解读。
Am J Kidney Dis. 2015 Mar;65(3):354-66. doi: 10.1053/j.ajkd.2014.10.005. Epub 2014 Nov 18.
9
Hypertension Management in Chronic Kidney Disease and Diabetes: Lessons from the Systolic Blood Pressure Intervention Trial.慢性肾脏病和糖尿病中的高血压管理：来自收缩压干预试验的经验。
Cardiol Clin. 2019 Aug;37(3):307-317. doi: 10.1016/j.ccl.2019.04.006. Epub 2019 May 8.
10
Canadian Society of Nephrology commentary on the KDIGO clinical practice guideline for CKD evaluation and management.加拿大肾脏病学会关于 KDIGO 慢性肾脏病评估和管理临床实践指南的评论。
Am J Kidney Dis. 2015 Feb;65(2):177-205. doi: 10.1053/j.ajkd.2014.10.013. Epub 2014 Nov 4.

引用本文的文献

1
Management of rituximab in patients with PLA2R-associated membranous nephropathy of different age: a single-center retrospective cohort study.不同年龄的磷脂酶A2受体相关膜性肾病患者的利妥昔单抗治疗：一项单中心回顾性队列研究
Ren Fail. 2025 Dec;47(1):2555688. doi: 10.1080/0886022X.2025.2555688. Epub 2025 Sep 7.
2
Quality of care for people with chronic kidney disease: a systematic review and meta-analysis.慢性肾病患者的护理质量：一项系统综述与荟萃分析
BMJ Open. 2025 Sep 4;15(9):e102044. doi: 10.1136/bmjopen-2025-102044.
3
Branched-chain amino acids contribute to diabetic kidney disease progression via PKM2-mediated podocyte metabolic reprogramming and apoptosis.
支链氨基酸通过PKM2介导的足细胞代谢重编程和凋亡促进糖尿病肾病进展。
Nat Commun. 2025 Aug 25;16(1):7846. doi: 10.1038/s41467-025-62890-9.
4
Factors shaping physical activity engagement in patients with moderate to advanced stage of chronic kidney disease from a hospital-based cross-sectional study, Bangladesh.来自孟加拉国一项基于医院的横断面研究：影响中晚期慢性肾病患者身体活动参与度的因素
BMC Nephrol. 2025 Aug 22;26(1):481. doi: 10.1186/s12882-025-04409-4.
5
Usefulness of A Random Spot Urine Proteins-to-Creatinine Ratio to Screen for Increased Albuminuria in Patients with Type 1 Diabetes.随机点尿蛋白与肌酐比值用于筛查1型糖尿病患者蛋白尿增加的效用
Rep Biochem Mol Biol. 2025 Jan;13(4):561-569. doi: 10.61186/rbmb.13.4.561.
6
The role of cystatin C in kidney injury in children and adolescents with type 1 diabetes mellitus: a systematic review.胱抑素C在1型糖尿病儿童和青少年肾损伤中的作用：一项系统评价
J Bras Nefrol. 2025 Oct-Dec;47(4):e20240236. doi: 10.1590/2175-8239-JBN-2024-0236en.
7
Influence of Genomic Ancestry and Other Traditional Risk Factors on the Prevalence of Diabetic Peripheral Neuropathy in Admixed Individuals With Type 1 Diabetes in Brazil: A Pioneer Multicenter Study.基因组血统和其他传统风险因素对巴西1型糖尿病混合个体中糖尿病周围神经病变患病率的影响：一项开创性的多中心研究。
J Peripher Nerv Syst. 2025 Sep;30(3):e70049. doi: 10.1111/jns.70049.
8
Impact of Methicillin-Resistant Nasal PCR Versus Culture on Vancomycin Utilization in Pneumonia Management.耐甲氧西林鼻拭子PCR检测与培养对肺炎治疗中万古霉素使用的影响
J Pharm Technol. 2025 Aug 6:87551225251359508. doi: 10.1177/87551225251359508.
9
Alterations in serum exosomal miR-1207-5p levels reflect severity and progression risk in type 2 diabetic kidney disease.血清外泌体miR-1207-5p水平的改变反映了2型糖尿病肾病的严重程度和进展风险。
BMC Nephrol. 2025 Aug 6;26(1):440. doi: 10.1186/s12882-025-04360-4.
10
Commentary on "Association of Serum Total Bilirubin to Cholesterol Ratio With Progression of Chronic Kidney Disease in Patients With Type 2 Diabetes: A Retrospective Cohort Study".《血清总胆红素与胆固醇比值与2型糖尿病患者慢性肾脏病进展的关联：一项回顾性队列研究》述评
J Diabetes. 2025 Jul;17(7):e70129. doi: 10.1111/1753-0407.70129.